Q & A on the investigational vaccine candidate M72/AS01E
M72/AS01E is a subunit vaccine comprised of an immunogenic fusion protein (M72) derived from two Mycobacterium tuberculosis (M.tb) antigens (MTB32A and MTB39A), and the GlaxoSmithKline (GSK) proprietary adjuvant AS01E. AS01E is the same adjuvant used in Shingrix GSK vaccine, as well as in the new malaria vaccine RTS,S/AS01E. The M72/AS01E vaccine candidate is being developed by the pharmaceutical company GlaxoSmithKline, in partnership with AERAS. AERAS is a not for profit organization based in the US, aimed at supporting tuberculosis vaccine research, funded by the Bill and Melinda Gates foundation, the UK Department for ...
Source: WHO Feature Stories - October 10, 2018 Category: International Medicine & Public Health Tags: tuberculosis [subject], tb Source Type: news

BCG vaccine may reduce blood sugar in type-1 diabetics
Research, presented at the European Association for the Study of Diabetes conference, suggests that the bacillus Calmette-Guerin vaccine is effective at reducing blood sugar levels in people with type-1 diabetes.MedicalXpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - October 5, 2018 Category: Endocrinology Source Type: news

Uganda:Ugandan Medic Develops New TB Vaccine for Adults
[Monitor] Kampala -A Ugandan medical doctor, Dr Jacqueline Akite, together with a team of other international scientists have registered landmark success by developing a new vaccine that stops the spread of pulmonary tuberculosis (TB) in adults. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - September 28, 2018 Category: Infectious Diseases Source Type: news

TB vaccine shows promise against diabetes
For Hodalis Gaytan, 20, living with Type 1 diabetes means depending on an assortment of expensive medicines and devices to stay healthy. Test strips. Needles. A glucose meter. Insulin. (Source: CNN.com - Health)
Source: CNN.com - Health - July 12, 2018 Category: Consumer Health News Source Type: news

Mixed Results with TB Vaccines in Trial
(MedPage Today) -- No difference for initial infection, but reduced rates of sustained QFT conversions versus placebo (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - July 11, 2018 Category: American Health Source Type: news

NEJM publishes final results from phase two study showing vaccines can reduce rate of sustained TB infections
(Burness) Aeras, a nonprofit organization dedicated to developing vaccines against tuberculosis (TB), today announced the publication of the full results from a Phase 2, randomized, controlled clinical trial of two TB vaccines-- the currently available BCG vaccine and an investigational vaccine, H4:IC31--in the New England Journal of Medicine (NEJM). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 11, 2018 Category: Infectious Diseases Source Type: news

Nigeria:BCG Can Reverse Type 1 Diabetes to Almost Undetectable Levels, Eight-Year Study Shows
[Guardian] An eight-year study has shown the Bacillus Calamine Guerin (BCG) vaccine against tuberculosis can reverse Type 1 diabetes to almost undetectable levels. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 26, 2018 Category: African Health Source Type: news

TB Vaccine for T1D Study Stirs Controversy
(MedPage Today) -- Long-term data suggest BCG vaccine may alter immune attack (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 25, 2018 Category: American Health Source Type: news

Possible cure for diabetes? Generic drug can reverse type 1 diabetes long-term, study finds
Research at Massachusetts General Hospital looks increasingly like a long-term cure for type 1 diabetes, with a newly released study showing patients have normal blood sugar levels eight years after a clinical trial. In research published in journal npj Vaccines, patients who had been treated with the Bacillus Calmette-Guerin (BCG) vaccine — an inexpensive, generic vaccine used around the world to prevent tuberculosis — had normal blood sugar levels eight years after the trial ended. While… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 25, 2018 Category: Pharmaceuticals Authors: Jessica Bartlett Source Type: news

TB Vaccine Linked to Better Type 1 Diabetes Control
Title: TB Vaccine Linked to Better Type 1 Diabetes ControlCategory: Health NewsCreated: 6/21/2018 12:00:00 AMLast Editorial Review: 6/22/2018 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - June 22, 2018 Category: Endocrinology Source Type: news

BCG Vaccine Tied to Reduced Hyperglycemia in Type 1 Diabetes
THURSDAY, June 21, 2018 -- The Bacillus Calmette Gu érin (BCG) vaccine is associated with a reduction in hyperglycemia among patients with type 1 diabetes with long-term disease, according to a study published online June 21 in npj Vaccines. Willem... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 21, 2018 Category: Pharmaceuticals Source Type: news

There ’s Hope for a Vaccine to Prevent Type 1 Diabetes
Could a vaccine for type-1 diabetes be on the horizon? In a new study, a small group of people with type 1 diabetes who were given a vaccine showed improvement in their blood sugar levels to nearly normal levels—and the changes lasted for five to eight years. The study, published Thursday in the journal npj Vaccines by researchers at Massachusetts General Hospital, looked at nine people with type 1 diabetes who were given a vaccine to prevent tuberculosis, called bacillus Calmette-Guérin (BCG). They had two injections, four weeks apart. Levels of their hemoglobin a1c (HbA1c), which measures a person’s bl...
Source: TIME: Health - June 21, 2018 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized diabetes healthytime Source Type: news

Generic drug shows promise as diabetes vaccine in small, years-long study
A cheap, generic tuberculosis vaccine lowered blood glucose levels in nine patients with Type I diabetes and the effects lasted for years, according to a study published this week in npj Vaccines. The study was conducted at Massachusetts General Hospital by Dr. Denise Faustman – a name that has long been saddled with controversy in the diabetes community, due in large part to a dispute with the JDRF after the organization declined to fund her work. Get the full story at our sister site, Drug Delivery Business News. The post Generic drug shows promise as diabetes vaccine in small, years-long s...
Source: Mass Device - June 21, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Pharmaceuticals Research & Development Massachusetts General Hospital Source Type: news

TB Vaccine Tied to Better Type 1 Diabetes Control
A little more than three years after getting two tuberculosis shots four weeks apart, about 50 people with type 1 diabetes saw their long-term average blood sugar levels drop significantly -- and for at least five years. (Source: WebMD Health)
Source: WebMD Health - June 21, 2018 Category: Consumer Health News Source Type: news

TB Vaccine Linked to Better Type 1 Diabetes Control
A little more than three years after getting two tuberculosis shots four weeks apart, about 50 people with type 1 diabetes saw their long-term average blood sugar levels drop significantly -- and for at least five years. (Source: WebMD Health)
Source: WebMD Health - June 21, 2018 Category: Consumer Health News Source Type: news

Diabetes Breakthrough: Common Vaccine Can Improve Blood Sugar Levels Long-Term
BOSTON (CBS) – Researchers at Mass General Hospital announced a breakthrough in treating Type 1 Diabetes. In a long-term study released Thursday, patients in a clinical trial had their blood sugar levels restored to near normal, with lasting results. Patients in the trial received two doses of the bacillus Calmette-Guerin (BCG) vaccine, an inexpensive vaccine that is widely used to prevent tuberculosis. Results were not immediate, but after three years, every patient, “showed an improvement in HbA1c to near normal levels – improvement that persisted for the following five years,” MGH said in a news ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - June 21, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated Local Diabetes Mass General Hospital Source Type: news

Study finds generic drug can reverse type 1 diabetes long-term
Research at Massachusetts General Hospital looks increasing like a long-term cure for type 1 diabetes, with a newly released study on Thursday showing patients have normal blood sugar levels eight years after a clinical trial. In research published Thursday in journal npj Vaccines, patients who had been treated with the bacillus Calmette-Guerin (BCG) vaccine — an inexpensive, generic vaccine used around the world to prevent tuberculosis — had normal blood sugar levels eight years after the… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 21, 2018 Category: American Health Authors: Jessica Bartlett Source Type: news

Researcher closes in on drug to reverse Type I diabetes
Research at Massachusetts General Hospital looks increasingly like a long-term cure for type 1 diabetes, with a newly released study showing patients have normal blood sugar levels eight years after a clinical trial. In research published Thursday in journal npj Vaccines, patients who had been treated with the bacillus Calmette-Guerin (BCG) vaccine — an inexpensive, generic vaccine used around the world to prevent tuberculosis — had normal blood sugar levels eight years after the trial ended.… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 21, 2018 Category: American Health Authors: Jessica Bartlett Source Type: news

Are the BCG jabs a solution to type 1 diabetes? Patients' blood sugars drop to near-normal levels
Researchers from the Massachusetts General Hospital found that the BCG vaccines may increase glucose uptake by cells, which causes patient's blood-sugar levels to decrease. (Source: the Mail online | Health)
Source: the Mail online | Health - June 21, 2018 Category: Consumer Health News Source Type: news

TB Vaccine Linked to Better Type 1 Diabetes Control
THURSDAY, June 21, 2018 -- Could a vaccine from the early 1900s be the key to preventing serious diabetes complications? Maybe, say researchers from Harvard University and Massachusetts General Hospital. A little more than three years after getting... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 21, 2018 Category: General Medicine Source Type: news

MGH study finds generic drug can reverse Type I diabetes long-term
Research at Massachusetts General Hospital looks increasing like a long-term cure for type 1 diabetes, with a newly released study on Thursday showing patients have normal blood sugar levels eight years after a clinical trial. In research published Thursday in journal npj Vaccines, patients who had been treated with the bacillus Calmette-Guerin (BCG) vaccine — an inexpensive, generic vaccine used around the world to prevent tuberculosis — had normal blood sugar levels eight years after the… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - June 21, 2018 Category: Health Management Authors: Jessica Bartlett Source Type: news

Speeding up the search for tuberculosis vaccines
An EU-funded project aims to identify and maximise the potential of novel vaccines to end the global tuberculosis epidemic. These could save lives, stem the spread of infection and shorten treatment for the often deadly, airborne disease. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - June 21, 2018 Category: Research Source Type: news

Cost and scale of field trials for bovine TB vaccine may make them unfeasible
(University of Cambridge) Field trials for a vaccination to protect cattle against bovine tuberculosis (bovine TB) would need to involve 500 herds -- potentially as many as 75,000-100,000 cattle -- to demonstrate cost effectiveness for farmers, concludes a study published today in the journal eLife. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 7, 2018 Category: Infectious Diseases Source Type: news

How intestinal worms hinder tuberculosis vaccination
(PLOS) New research in mice suggests that chronic infection with intestinal worms indirectly reduces the number of cells in lymph nodes near the skin, inhibiting the immune system's response to the Bacille Calmette-Guerin (BCG) vaccine for tuberculosis. Xiaogang Feng of Karolinska Institutet in Stockholm, Sweden, and colleagues present these findings in PLOS Pathogens. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 17, 2018 Category: Infectious Diseases Source Type: news

Publication details IDRI's promising leprosy vaccine candidate
(Infectious Disease Research Institute) A publication in Nature Partner Journals (npj) Vaccines indicates that post-exposure prophylaxis with LepVax, IDRI's leprosy vaccine candidate, not only appears safe but, unlike BCG (a tuberculosis vaccine that provides some protection against leprosy), alleviates and delays the neurologic disruptions caused by Mycobacterium leprae infection in nine-banded armadillos. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 26, 2018 Category: Infectious Diseases Source Type: news

TB vaccine trial results offer potential for BCG Revaccination, hope for subunit vaccines
(Burness) Aeras, a nonprofit organization dedicated to developing vaccines against tuberculosis (TB), today announced results from an innovative clinical trial that provides encouraging new evidence that TB vaccines could prevent sustained infections in high-risk adolescents. In a prevention-of-infection Phase 2 trial conducted in South Africa, revaccination with the Bacille Calmette-Guerin (BCG) vaccine significantly reduced sustained TB infections in adolescents. An experimental vaccine candidate, H4:IC31, also reduced sustained infections, although not at statistically significant levels. (Source: EurekAlert! - Infectio...
Source: EurekAlert! - Infectious and Emerging Diseases - February 19, 2018 Category: Infectious Diseases Source Type: news

Inovio lands $4.6M in funding for malaria, tuberculosis vaccines
Inovio Pharmaceuticals Inc. said Monday it has received $4.6 million in grant funding from the Bill& Melinda Gates Foundation and the National Institutes of Health to advance work on vaccine programs targeting tuberculosis and malaria. The Plymouth Meeting biopharmaceutical company is conducting its research as part of its partnership with the Wistar Institute of Philadelphia. Both programs involve the use of Inovio's SynCon synthetic vaccine technology that helps a person's own immune system… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 12, 2018 Category: Pharmaceuticals Authors: John George Source Type: news

South Africa:IFP - Medicines Control Council Must Urgently Approve Bacillus Calmette Guerin Vaccine
[IFP] The Inkatha Freedom Party calls on the Medicines Control Council to urgently approve the all-important Bacillus Calmette-Gu érin (BCG) vaccine, which protects the child from severe types of Tuberculosis (TB). (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 31, 2018 Category: African Health Source Type: news

TB vaccine SCAM: Scientists gave 1,400 babies a new vaccine for tuberculosis despite FAILED safety trials
(Natural News) An investigation by the British Medical Journal has exposed a horrifying vaccine scam that took place in the same place that many unethical vaccine stories come from – Africa. There, babies were used as guinea pigs to test out a vaccine after the monkeys it was tested on died. According to the report,... (Source: NaturalNews.com)
Source: NaturalNews.com - January 21, 2018 Category: Consumer Health News Source Type: news

Fresh approach to TB vaccine offers better protection
(Oregon Health& Science University) A unique platform that resulted in a promising HIV vaccine has also led to a new, highly effective vaccine against tuberculosis that is moving toward testing in humans. The new vaccine completely protected 41 percent and reduced overall TB disease by 68 percent in vaccinated rhesus macaques, according to a study published as an Advanced Online Publication of Nature Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 17, 2018 Category: International Medicine & Public Health Source Type: news

Investigation Raises Concerns About Animal Study Misreporting
(MedPage Today) -- TB vaccine debacle traced to cherry-picked results from preclinical models (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - January 11, 2018 Category: American Health Source Type: news

TB vaccine that killed monkeys given to 1,400 babies
An information sheet given to the parents of the babies said the vaccine had been tested on animals and was ‘shown to be safe and effective’. But it did not mention the failed monkey trial. (Source: the Mail online | Health)
Source: the Mail online | Health - January 11, 2018 Category: Consumer Health News Source Type: news

Bacillus Calmette-Guerin Vaccination and Childhood Asthma Bacillus Calmette-Guerin Vaccination and Childhood Asthma
While some have speculated that BCG vaccination in infancy might protect against childhood asthma, the results of this study proved disappointing.American Journal of Epidemiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 3, 2017 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news

Scientists ignored fatal results of TB vaccine, went ahead with trials on human babies
(Natural News) While testing on animals is an undoubtedly detestable practice, it still pales in comparison to testing on human babies. Especially when the product in question has already been shown to kill primates, our close genealogical relatives. But for Big Pharma and other vaccine-pushers, human life is of little consequence — even when talking... (Source: NaturalNews.com)
Source: NaturalNews.com - September 28, 2017 Category: Consumer Health News Source Type: news

How tuberculosis hides in the body
(Norwegian University of Science and Technology) The tuberculosis vaccine only works for children. BCG (bacille Calmette-Guerin) doesn't protect you as an adult. Now we know more about how the bacterium avoids being detected, which is an important step towards better treatment. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 28, 2017 Category: Infectious Diseases Source Type: news

Global Health: Lasting Merit Found in a Tuberculosis Vaccine Invented a Century Ago
BCG vaccine, used in many countries, protects for nearly twice as long as previously thought, scientists find. (Source: NYT Health)
Source: NYT Health - September 1, 2017 Category: Consumer Health News Authors: DONALD G. McNEIL Jr. Tags: Vaccination and Immunization Tuberculosis International Journal of Epidemiology Source Type: news

TB vaccine BCG effective for twice as long as previously thought – study
Benefits of world ’s only vaccine against tuberculosis were underestimated as new findings reveal it protects against the disease for at least 20 yearsThe BCG, an old vaccine but the only one against tuberculosis, is more effective than was thought, offering protection for at least 20 years, a new study shows.BCG vaccination used to be routine in all secondary schools in the UK for young teenagers, but in recent years it has been given only to those at risk, such as children living in inner-city areas with relatively high TB rates.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - August 31, 2017 Category: Science Authors: Sarah Boseley Health editor Tags: Medical research Tuberculosis Health Society Science UK news Source Type: news

BCG jab may protect against TB for nearly twice as long as previously thought
(London School of Hygiene& Tropical Medicine) The world's only licensed tuberculosis (TB) vaccine could offer protection against the disease for nearly twice as long as previously thought, according to new research published in the International Journal of Epidemiology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 31, 2017 Category: International Medicine & Public Health Source Type: news

Texas Biomed and UT Health Houston to team on $4.4M tuberculosis vaccine study
Researchers from San Antonio and the Bayou City are working to create an improved vaccine to fight the deadly disease. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 22, 2017 Category: American Health Authors: W. Scott Bailey Source Type: news

Texas Biomed and UT Health Houston to team on $4.4M tuberculosis vaccine study
Researchers from San Antonio and the Bayou City are working to create an improved vaccine to fight the deadly disease. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 21, 2017 Category: Pharmaceuticals Authors: W. Scott Bailey Source Type: news

TX Biomed part of team on 5-year, $4.4 million NIH grant for novel TB vaccine testing
(Texas Biomedical Research Institute) Texas Biomedical Research Institute Associate Scientist Dr. Marie-Claire Gauduin has partnered with Dr. Chinnaswamy Jagannath, professor at McGovern Medical School at UTHealth in Houston to test a modified TB vaccine that, if effective, could prove more powerful and provide longer lasting immunity. Dr. Gauduin and Dr. Jagannath are principal investigators on this five-year, $4.4 million study funded by the National Institutes of Health. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 21, 2017 Category: International Medicine & Public Health Source Type: news

Tuberculosis Vaccine Candidate MTBVAC Shows Differential Protection Compared With BCG
According to Dr. Nacho Aguiló first author of the study, "there are no specific antigens associated with the efficacy of (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - July 18, 2017 Category: Consumer Health News Source Type: news

Why Big Pharma doesn't want a promising drug to reverse type 1 diabetes
​Dr. Denise Faustman has been working for eight years on using a low-cost tuberculosis vaccine to permanently reverse type I diabetes. But pharmaceutical companies have no interest. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 15, 2017 Category: American Health Authors: Jessica Bartlett Source Type: news

Mass. General study finds potential mechanism for BCG vaccine reversal of type 1 diabetes
(Massachusetts General Hospital) Interim results from a FDA-approved clinical trial testing the generic vaccine bacillus Calmette-Gu é rin to reverse advanced type 1 diabetes demonstrate a potential new mechanism by which the BCG vaccine may restore the proper immune response to the insulin-secreting islet cells of the pancreas. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 10, 2017 Category: International Medicine & Public Health Source Type: news

Dartmouth Tuberculosis Vaccine Passes Important Milestone
Investigators at Dartmouth’s Geisel School of Medicine announced that two new studies of DAR-901, their investigational vaccine against tuberculosis (TB), have moved it to the forefront of new vaccines in development for global control of this deadly infectious disease. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - May 11, 2017 Category: Hospital Management Authors: Geisel Communications Tags: News DAR-901 DarDar Features Ford Von Reyn global health research TB tuberculosis vaccine Source Type: news

Dartmouth tuberculosis vaccine passes important milestone
(The Geisel School of Medicine at Dartmouth) Investigators at Dartmouth's Geisel School of Medicine announced that two new studies of DAR-901, their investigational vaccine against tuberculosis (TB), have moved it to the forefront of new vaccines in development for global control of this deadly infectious disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 11, 2017 Category: Infectious Diseases Source Type: news

Tuberculosis vaccine safe for teens with Schistosoma parasite
(PLOS) Of the millions of people at risk for contracting tuberculosis each year, many are already infected with helminths, parasitic worms including Schistosoma flatworms. In some cases, parasite infections can impair the ability of an immunization to work. But adolescents infected with Schistosoma mansoni respond as well as uninfected teens do to a candidate booster tuberculosis vaccine, according to a new study in PLOS Neglected Tropical Diseases. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 4, 2017 Category: Infectious Diseases Source Type: news

Health risk of unlicensed drugs in herbal supplements
Experts say those taking supplements should inform their GP Related items fromOnMedica Vitamin D supplements reduce severe asthma attacks Experts recommend everyone take vitamin D supplements New leaflet eases fears over unlicensed BCG vaccine Vitamin D supplements in pregnancy don ’t boost babies’ bone strength No strong evidence that omega 3 supplements alleviate depression (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 5, 2017 Category: UK Health Source Type: news

When Men and Women Differ
By Drs. David Niesel and Norbert Herzog Besides the obvious physical differences, science is beginning to tease out some significant biological differences between men and women that have implications for women's health. A call to action was the measles vaccine that the World Health Organization suddenly had to withdraw after the deaths of infant girls increased but not boys. The cause remains unclear, but it served as a wakeup call to science to pay attention to gender differences when evaluating or testing drugs or vaccines. Fifteen years ago, it was discovered that women infected with HIV, are usually infected by ma...
Source: Science - The Huffington Post - January 25, 2017 Category: Science Source Type: news